Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 7.205 0.195 (2.78%) Market Cap: 955.05 Mil Enterprise Value: 932.14 Mil PE Ratio: 0 PB Ratio: 2.32 GF Score: 82/100

Maravai LifeSciences Holdings Inc at UBS Global Healthcare Virtual Conference Transcript

May 25, 2021 / 09:00PM GMT
Release Date Price: $36.63 (+1.19%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Good afternoon. Welcome. I'm Dan Brennan. I cover tools and diagnostics in the pharma service stocks here for UBS. Pleased to be joining the virtual stage here with the senior management team of Maravai, who became public back in -- I believe, it was December, and we were involved on that IPO. End of day 2 of the conference, but certainly really looking forward to digging into the story with both Carl Hull, the CEO; and Kevin Herde, the Chief Financial Officer.

Carl, you'll be able to hear on the phone. Kevin, you'll be able to see on video. Please feel free -- for those on the webcast, if you'd like to try to shoot me a question in the webcast question link, please do so, and I'll check it throughout the presentation.

So first off, I would just say, Carl and Kevin, thanks for joining us here at the UBS conference.

Carl W. Hull
Maravai LifeSciences Holdings, Inc. - Co-Founder, Chairman & CEO

Well, thanks for having

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot